Multi-institution Evaluation of Adherence to Comprehensive Postoperative VTE Chemoprophylaxis
- PMID: 30632990
- PMCID: PMC6904538
- DOI: 10.1097/SLA.0000000000003124
Multi-institution Evaluation of Adherence to Comprehensive Postoperative VTE Chemoprophylaxis
Abstract
Objectives: The aims of this study were to: (1) measure the rate of failure to provide defect-free postoperative venous thromboembolism (VTE) chemoprophylaxis, (2) identify reasons for failure to provide defect-free VTE chemoprophylaxis, and (3) examine patient- and hospital-level factors associated with failure.
Summary background data: Current VTE quality measures are inadequate. VTE outcome measures are invalidated for interhospital comparison by surveillance bias. VTE process measures (e.g., SCIP-VTE-2) do not comprehensively capture failures throughout patients' entire hospitalization.
Methods: We examined adherence to a novel VTE chemoprophylaxis process measure in patients who underwent colectomies over 18 months at 36 hospitals in a statewide surgical collaborative. This measure assessed comprehensive VTE chemoprophylaxis during each patient's entire hospitalization, including reasons why chemoprophylaxis was not given. Associations of patient and hospital characteristics with measure failure were examined.
Results: The SCIP-VTE-2 hospital-level quality measure identified failures of VTE chemoprophylaxis in 0% to 3% of patients. Conversely, the novel measure unmasked failure to provide defect-free chemoprophylaxis in 18% (736/4086) of colectomies. Reasons for failure included medication not ordered (30.4%), patient refusal (30.3%), incorrect dosage/frequency (8.2%), and patient off-unit (3.4%). Patients were less likely to fail the chemoprophylaxis process measure if treated at nonsafety net hospitals (OR 0.62, 95% CI 0.39-0.99, P = 0.045) or Magnet designated hospitals (OR 0.45, 95% CI 0.29-0.71, P = 0.001).
Conclusions: In contrast to SCIP-VTE-2, our novel quality measure unmasked VTE chemoprophylaxis failures in 18% of colectomies. Most failures were due to patient refusals or ordering errors. Hospitals should focus improvement efforts on ensuring patients receive VTE prophylaxis throughout their entire hospitalization.
Conflict of interest statement
The authors report no conflicts of interest.
Figures
Similar articles
-
Development of a Novel Composite Process Measure for Venous Thromboembolism Prophylaxis.Med Care. 2016 Feb;54(2):210-7. doi: 10.1097/MLR.0000000000000474. Med Care. 2016. PMID: 26683781
-
Association Between Missed Doses of Chemoprophylaxis and VTE Incidence in a Statewide Colectomy Cohort.Ann Surg. 2021 Apr 1;273(4):e151-e152. doi: 10.1097/SLA.0000000000004349. Ann Surg. 2021. PMID: 33074868 Free PMC article. No abstract available.
-
The association of venous thromboembolism chemoprophylaxis timing on venous thromboembolism after major vascular surgery.J Vasc Surg. 2018 Jan;67(1):262-271.e1. doi: 10.1016/j.jvs.2017.06.087. Epub 2017 Sep 1. J Vasc Surg. 2018. PMID: 28870681 Free PMC article.
-
Chemoprophylaxis for Venous Thromboembolism in Operative Treatment of Fractures of the Tibia and Distal Bones: A Systematic Review and Meta-analysis.J Orthop Trauma. 2017 Sep;31(9):453-460. doi: 10.1097/BOT.0000000000000873. J Orthop Trauma. 2017. PMID: 28459774 Review.
-
Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.Cochrane Database Syst Rev. 2018 Apr 24;4(4):CD008201. doi: 10.1002/14651858.CD008201.pub3. Cochrane Database Syst Rev. 2018. PMID: 29687454 Free PMC article. Review.
Cited by
-
Comparison of pain after prophylactic anticoagulant injections to prevent venous thromboembolism.Surg Open Sci. 2024 Jun 18;20:98-100. doi: 10.1016/j.sopen.2024.06.001. eCollection 2024 Aug. Surg Open Sci. 2024. PMID: 39006205 Free PMC article.
-
Venous Thromboembolism Chemoprophylaxis Adherence Rates After Major Cancer Surgery.JAMA Netw Open. 2023 Sep 5;6(9):e2335311. doi: 10.1001/jamanetworkopen.2023.35311. JAMA Netw Open. 2023. PMID: 37768664 Free PMC article.
-
Development of the Illinois Surgical Quality Improvement Collaborative (ISQIC): Implementing 21 Components to Catalyze Statewide Improvement in Surgical Care.Ann Surg Open. 2023 Mar;4(1):e258. doi: 10.1097/AS9.0000000000000258. Epub 2023 Mar 1. Ann Surg Open. 2023. PMID: 36891561 Free PMC article.
-
Natural language processing for the surveillance of postoperative venous thromboembolism.Surgery. 2021 Oct;170(4):1175-1182. doi: 10.1016/j.surg.2021.04.027. Epub 2021 Jun 3. Surgery. 2021. PMID: 34090671 Free PMC article.
-
Post-discharge venous thromboembolism after pancreatectomy for malignancy: Predicting risk based on preoperative, intraoperative, and postoperative factors.J Surg Oncol. 2020 Sep;122(4):675-683. doi: 10.1002/jso.26046. Epub 2020 Jun 12. J Surg Oncol. 2020. PMID: 32531819 Free PMC article.
References
-
- Mismetti P, Laporte S, Darmon JY, et al. Meta-analysis of low molecular-weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg. 2001;88:913–930. - PubMed
-
- Rasmussen MS, Jorgensen LN, Wille-Jorgensen P. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery. Cochrane Database Syst Rev. 2009;(1):CD004318. - PubMed
-
- Shojania KGMK, Wachter RM, Owens DK. Closing The Quality Gap: A Critical Analysis of Quality Improvement Strategies, Volume 1—Series Overview and Methodology Technical Review 9 (Contract No. 290–020017 to the Stanford University–UCSF Evidence based Practices Center). Agency for Healthcare Research and Quality. - PubMed
-
- Bilimoria KY, Chung J, Ju MH, et al. Evaluation of surveillance bias and the validity of the venous thromboembolism quality measure. JAMA. 2013;310:1482–1489. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
